Press Releases

Angioplasty Balloons & Stents Market 2022| Worldwide Share, Global Trends, Boost Growth, Fuel Demand by 2030

Complications with Existing Treatments to Drive Innovations

The healthcare sector is no stranger to innovations and technological advancements. Research and development activities continue to improve the efficacy of treatments and bring forward new therapies to treat a range of diseases. Over the past couple of decades, minimally invasive procedures have gained a great amount of popularity within the healthcare sector. A similar trend can be observed within the angioplasty balloons & stents market as the adoption of minimally invasive procedures is on the rise, particularly among patients who have been diagnosed with coronary heart diseases or experienced a heart attack.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111668

At present, healthcare experts are focusing on minimizing the complications involved with the percutaneous coronary intervention (PCI) by leveraging the benefits of technology that continue to improve the effectiveness and safety of these treatments. The advent of different types of stents coupled with technological progress is likely to play an important role in boosting the growth of the market for angioplasty balloons & stents during the forecast period. Companies operating in the current market landscape are also expected to focus on the development of scaffold designs, use of dual antiplatelet therapy, and delivery of anti-proliferative agents have played an important role in minimizing the stent thrombosis and restenosis rates. Complications involved with the existing angioplasty balloons and stents are anticipated to drive innovations in the angioplasty balloons & stents market that is expected to reach ~US$ 9 Bn by 2027.

Noteworthy Developments in Coronary Stent Technology to Augment Market

Since its introduction in the 1970s, coronary artery balloon angioplasty has emerged as one of the most effective and ideal alternative treatment to the coronary artery bypass surgery. With significant progress in scaffold designs and promising outcomes from research & development, the global angioplasty balloons & stents market is expected to witness steady growth in the coming years. Bioabsorbable stent scaffolds are increasingly being used worldwide and are predominantly made from bioabsorbable polymer backbone and polymer coating of poly-D and L-lactide, which is an anti-proliferative drug. Over the years, this stent type has gained a considerable amount of popularity, as it has offered imaging and clinical results that are similar to that of traditional drug eluting stents (DES). Several companies within the angioplasty balloons & stents market are rolling out different types of stents to gain an edge in the current market landscape. For instance, the IDEAL BDS stent introduced by Bioabsorbable Therapeutics consists of salicylic acid and polyanhydride ester– ingredients that contain anti-inflammatory and antiproliferative elements.

Get a glimpse of the in-depth analysis through our Report Brochure

Drug-eluting stents are expected to remain the most popular product type within the angioplasty balloons and stents. Owing to research and advancements in technology, the demand for drug-eluting balloons has witnessed considerable growth in recent times– a trend set to continue during the forecast period. As the adoption of balloon angioplasty continues to rise, the demand for the drug-eluting balloon is experiencing a considerable surge as well. Drug-eluting balloons are increasingly being used in the treatment for coronary vessels with small diameter. Moreover, drug-eluting balloons also enable the efficient application of anti-proliferative agents particularly during barotrauma due to which the adoption of metal scaffolds is expected to take a hit. Studies have revealed that balloon angioplasty procedures are as effective as Paclitaxel-eluting drug-eluting stents and notably better than traditional balloon angioplasty.

View full report@ https://qyresearchmedical.com/report/angioplasty-balloons-stents-market-product-stents-and-balloons-indication-coronary-artery-diseases-and-peripheral-artery-diseases-and-end-user-hospitals-ambulatory-surgical-centers-and-cath-labs-global-019-2030/111668

Research and Development Continue to Trigger New Innovations and Treatment Techniques

Research and development activities are driving the healthcare sector, as new treatments, therapies, and medication are increasingly being used to address problems related to small blocked arteries. Recent studies that are investigating different treatment types have revealed that the removable balloon has exhibited the same levels of effectiveness as that of permanent stent implants, especially to open up small blocked arteries. Experts operating in the angioplasty balloons & stents market are of the opinion that drug-coated balloon angioplasty could potentially become the gold standard treatment for small blocked arteries. However, with added research, newer alternatives could enter the angioplasty balloons & stents market during the forecast period. Over the past few years, vendors in the angioplasty balloons & stents market are focusing on the development of improved stent technologies for the treatment of peripheral artery diseases.

Analysts’ Viewpoint

The global angioplasty balloons & stents market is expected to grow at a moderate CAGR of 4.5% during the forecast period. The market growth can be primarily attributed to a host of factors, including the advent of bioabsorbable stents, rise in the geriatric population worldwide, high prevalence of cardiovascular diseases, favorable reimbursement policies, and research and development. Technological advancements will play a key role in the development of new and improved angioplasty balloons and stents. Companies operating in the angioplasty balloons & stents market should focus on research and aim to attain approval for their products to gain an edge in the current market landscape.

Angioplasty Balloons & Stents Market: Overview

Angioplasty is a procedure, which opens narrowed arteries. During the procedure, a long, thin tube called catheter, which has a small balloon on its tip, is used to open the blockage. In some cases, a mesh-like device made of metal is placed inside an artery, which helps to improve blood flow. Stent procedures are usually performed, along with balloon angioplasty. The global angioplasty balloons & stents market is projected to expand significantly, due to increase in incidence of cardiovascular disease across the world.

Cardiovascular diseases are a major health concern, with prevalence rising rapidly across the globe. Changing lifestyle, increase in obesity, and addiction to alcohol are the major risk factors for heart diseases.

Angioplasty Balloons & Stents Market: Drivers

According to the American College of Cardiology, the number of people with peripheral artery disease across the globe increased from 164 million in 2004 to 202 million in 2010. Moreover, prevalence of peripheral artery disease is rising in low- and middle-income countries, especially in Southeast Asia and Western Pacific. Furthermore, according to the American Heart Association, in 2018, cardiovascular diseases accounted for nearly 836,546 deaths in the U.S. i.e., one in every three deaths. This factor boosts the demand for balloons and stents, which in turn is expected to drive the global angioplasty balloons and stents market.

Increase in the number of cardiac procedures using stents has led to the rise in the adoption of drug-eluting stents. The number of percutaneous coronary interventions (PCI) has also increased at a steady pace.

According to the Fortis Escorts Heart Institute, in 2016, around 594,000 stents were used in 495,000 PCIs in India, with DES accounting for 80% of the stents implanted

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111668/2900

Angioplasty Balloons & Stents: Market Segmentation

In terms of product, the global angioplasty balloons & stents market has been bifurcated into balloons and stents. The balloons segment has been split into drug-coated balloons and plain old balloons. The stents segment has been segregated into drug-eluting stents and bare metal stents.

Based on indication, the global angioplasty balloons & stents market has been classified into coronary artery disease and peripheral artery diseases

In terms of end user, the global angioplasty balloons & stents market has been divided into hospitals, ambulatory surgical centers, and cath labs

Each segment of the global angioplasty balloons & stents market has been analyzed in detail for market trends, recent trends, developments, drivers, restraints, opportunities, and useful insights

The report provides current and future revenue (US$ Mn) for each of these segments from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment of the global angioplasty balloons & stents market from 2019 to 2027, along with market size estimations.

Angioplasty Balloons & Stents Market: Regional Overview

In terms of region, the global angioplasty balloons & stents market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.

North America is expected to dominate the global angioplasty balloons & stents market during the forecast period. The angioplasty balloons & stents market in Asia Pacific is projected to expand at a high CAGR during the forecast period.

The current and future values in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2017 to 2027, along with their CAGRs for the period from 2019 to 2027

The study also offers a list of recommendations, highlights, and useful insights of the global angioplasty balloons and stents market, which would help new companies willing to enter the global market and existing companies to increase market shares and help in the decision-making process

Angioplasty Balloons & Stents Market: Major Players

The report concludes with the company profiles section that includes key information about the major players in the global angioplasty balloons and stents market

Key players analyzed in this report are 

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Cook Medical
  • Biosensors International Group, Ltd
  •  MicroPort Scientific Corporation
  • Terumo Corporation
  • Stentys SA
  • Biotronik, Inc.
  • BD

Each of these players has been profiled in the global angioplasty balloons & stents market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Key Questions Answered in Angioplasty Balloons & Stents Market Report

  • What is the sales/revenue generated by each product segment across all regions during the forecast period?
  • What are the opportunities in the global angioplasty balloons and stents market?
  • What are the major drivers, restraints, opportunities, and threats of the global angioplasty balloons and stents market?
  • Which regional market is likely to expand at the fastest CAGR during the forecast period?
  • Which angioplasty balloons and stents types are expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What was the market shares or positions of different companies operating in the global angioplasty balloons & stents market in 2018?

Angioplasty Balloons & Stents Market – Segmentation

Product

  • Stents
  • Drug-eluting Stents
  • Bare Metal Stents
  • Balloons
  • Drug-coated Balloons
  • Plain Old Balloons

Indication

  • Coronary Artery Diseases
  • Peripheral Artery Diseases

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cath Labs

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Angioplasty Balloons And Stents Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Angioplasty Balloons And Stents Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Technological Advancement

5.2. Regulatory Approval

5.3. Strategic Approaches, by Major Players

5.4. Product Launch

5.5. Clinical Trails

5.6. Re-imbursement Scenario

6. Global Angioplasty Balloons and Stents Market Analysis and Forecast, by Product, 2017–2027

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Product, 2017–2027

6.3.1. Stents

6.3.1.1. Drug-eluting Stents

6.3.1.2. Bare Metal Stents

6.3.2. Balloons

6.3.2.1. Drug-coated Balloons

6.3.2.2. Plain Old Balloons

6.4. Global Angioplasty Balloons and Stents Market Attractiveness Analysis, by Product

7. Global Angioplasty Balloons and Stents Market Analysis and Forecast, by Indication, 2017–2027

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Angioplasty Balloons and Stents Market Value Forecast, by Indication, 2017–2027

7.3.1. Coronary Artery Diseases

7.3.2. Peripheral Artery Diseases

7.4. Market Attractiveness, by Indication

8. Global Angioplasty Balloons and Stents Market Analysis and Forecast, by End-user

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global Angioplasty Balloons and Stents Market Value Forecast, by End-user, 2017–2027

8.3.1. Hospitals

8.3.2. Ambulatory Surgical Centers

8.3.3. Cath Labs

8.4. Global Angioplasty Balloons and Stents Market Attractiveness Analysis, by End-user

9. Global Angioplasty Balloons and Stents Market Analysis and Forecast, by Region, 2017–2027

……

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111668/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Show More

Related Articles

Back to top button